Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|27|4904-4912

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.27, 2013-08, pp. : 4904-4912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Standing Statin Therapy and the Risk of New-Onset Diabetes in the Elderly: Collateral Damage Caused by Preventive Medicine?

By Mascitelli Luca  

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite

Statins and New-Onset Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3657-3664

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Antimicrobial Resistance: Their Clinical Relevance in the New Millennium

By Sefton A.M.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 557-566

Adis International

Access to resources Recommend Favorite

GAD-alum: balanced results in new-onset type 1 diabetes

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The Effect of Antihypertensive Agents on New-Onset Diabetes Mellitus: Time to Amend the Guidelines?

By Tonje Amb Aksnes  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 139-147

Adis International

Access to resources Recommend Favorite